Thomas Zimmer

ISPE
VP European Operations
Thomas Zimmer, PhD, is the Vice President of European Operations at ISPE. He previously served as Senior Vice President of the Corporate Division for Safety, Quality & Environmental Protection at Boehringer Ingelheim, where he worked from 1981 to 2015. During his tenure, he held various positions in pharmaceutical development, manufacturing, and management operations across the Americas and Europe. He also led the Project Production Alliance Europe and later became Head of Pharma Operations in France.

Thomas chaired the Anti-Counterfeiting Ad Hoc Group for nine years and was a member of the Scientific, Technical, and Regulatory Policy Committee (STPR) at the European Federation of Pharmaceutical Industries Associations (EFPIA). He also chaired the Industry Advisory Board for the Institute for Packaging at the University of Applied Sciences in Berlin. At ISPE, he is a member of the International Leadership Forum (ILF) and serves on the board of the Pharmaceutical Security Institute (PSI), an organisation of major pharmaceutical companies dedicated to combating counterfeit medicines. Additionally, he actively participates in several global ISPE initiatives, including those focused on Drug Shortages.

Thomas is a member of the French Académie Nationale de Pharmacie (ANP) at the University of Paris. He studied pharmacy at Johann Wolfgang Goethe University in Frankfurt/Main, where he completed his doctoral thesis in pharmaceutical technology.

Related Articles

Pharma 4.0™ operating model
Online Exclusives
Pharma 4.0™ Is Gaining Momentum and Driving Innovation

The fifth Pharma 4.0™ conference was held December 2022 in Vienna, Austria, in combination with the Aseptic Processing conference. Nearly 500 participants attended either in person or online to learn about the latest developments.

2022 Ispe Europe Annual Conference Madrid: In-Person Again
InTouch
2022 ISPE Europe Annual Conference Madrid: In-Person Again

The ninth ISPE Europe Annual Conference was the first in-person conference after a break of over two years due to the pandemic. For travel-related reasons, some attendees participated remotely. With 450 participants on-site and nearly 490 total attendees, the usual atmosphere of an

The holistic supply chain
Features
Holistic Control Strategy: From ICH Quality Guidelines to Pharma 4.0™

The fourth Industrial Revolution (also known as Industry 4.0) is the era of smart machines, storage systems, and production plants that can autonomously exchange information, trigger actions, and control operations free of any human intervention. To ensure future success in the delivery of therapeutic medicines to patients, it is imperative that the pharmaceutical industry move deeper into the...

Plenary session at the 2019 ISPE Europe Biotechnology Conference in Brussels in September 2019.
Features
2019 ISPE Europe Biotechnology Conference: Industry Transformations

As biopharmaceuticals have become a major part of the pharmaceutical industry, we have witnessed significant transformations in product development, strategy, technology, and operations. This ongoing transformational process was the main theme of the fourth annual